Page 99 - Read Online

Kozarov et al. Vessel Plus 2020;4:10 I http://dx.doi.org/10.20517/2574-1209.2019.31 Page 13 of 18

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. Joseph P, Leong D, McKee M, Anand SS, Schwalm JD, et al. Reducing the global burden of cardiovascular disease, part 1: the
epidemiology and risk factors. Circ Res 2017;121:677-94.
2. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-
specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet
2016;388:1459-544.
3. Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, et al. Forecasting life expectancy, years of life lost, and all-cause and
cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.
Lancet 2018;392:2052-90.
4. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart
disease events. JAMA 2003;290:891-7.
5. Stampfer MJ, Ridker PM, Dzau VJ. Risk factor criteria. Circulation. 2004;109:IV3-5.
6. Kones R. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical
disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes. Vasc
Health Risk Manag 2013;9:617-70.
7. Libby P. The forgotten majority: unfinished business in cardiovascular risk reduction. J Am Coll Cardiol 2005;46:1225-8.
8. Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 2007;65:S140-6.
9. Seymour GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K. Relationship between periodontal infections and systemic disease. Clin
Microbiol Infect 2007;13:3-10.
10. Reyes L, Herrera D, Kozarov E, Roldá S, Progulske-Fox A. Periodontal bacterial invasion and infection: contribution to atherosclerotic
pathology. J Periodontol 2013;84:S30-50.
11. Pietiäinen M, Liljestrand JM, Kopra E, Pussinen PJ. Mediators between oral dysbiosis and cardiovascular diseases. Eur J Oral Sci
2018;126:26-36.
12. Carrizales-Sepúlveda EF, Ordaz-Farías A, Vera-Pineda R, Flores-Ramírez R. Periodontal disease, systemic inflammation and the risk
of cardiovascular disease. Heart Lung Circ 2018;27:1327-34.
13. Mesa F, Magan-Fernandez A, Castellino G, Chianetta R, Nibali L, et al. Periodontitis and mechanisms of cardiometabolic risk: Novel
insights and future perspectives. Biochim Biophys Acta Mol Basis Dis 2019;1865:476-84.
14. Kozarov E, Progulske-Fox A. Pocket guide to bacterial infections. In: Balamurugan K, Udayakumar P, editors. Boca Raton, FL: CRC
Press; 2019. pp. 398.
15. Bui FQ, Almeida-da-Silva CLC, Huynh B, Trinh A, Liu J, et al. Association between periodontal pathogens and systemic disease.
Biomed J 2019;42:27-35.
16. Liccardo D, Cannavo A, Spagnuolo G, Ferrara N, Cittadini A, et al. Periodontal disease: a risk factor for diabetes and cardiovascular
disease. Int J Mol Sci 2019;20:1414.
17. Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, et al.; CARDIoGRAMplusC4D Consortium. Large-scale association
analysis identifies new risk loci for coronary artery disease. Nat Genet 2013;45:25-33.
18. Björkegren JLM, Kovacic JC, Dudley JT, Schadt EE. Genome-wide significant loci: how important are they? Systems genetics to
understand heritability of coronary artery disease and other common complex disorders. J Am Coll Cardiol 2015;65:830-45.
19. JPatron J, Serra-Cayuela A, Han B, Li C, Wishart DS. Assessing the performance of genome-wide association studies for predicting
disease risk. PLoS One 2019;14:e0220215.
20. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999;340:115-26.
21. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
22. Libby P, Ridker PM, Hansson GK; Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from
pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-38.
23. Lowe GD. The relationship between infection, inflammation, and cardiovascular disease: an overview. Ann Periodontol 2001;6:1-8.
24. Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 2004;116:9S-16S.
25. Elkind MS. Infectious burden: a new risk factor and treatment target for atherosclerosis. Infect Disord Drug Targets 2010;10:84-90.
26. Elkind MS, Luna JM, Moon YP, Boden-Albala B, Liu KM, et al. Infectious burden and carotid plaque thickness: the Northern
Manhattan Study. Stroke 2010;41:e117-22.